Business Description Biomira Inc. is a product focused biotechnology company applying its proprietary immunotherapy and organic chemistry technologies for the development of cancer therapeutics. The Company's lead product, THERATOPE vaccine, is currently being tested in a Phase III clinical trial for metastatic breast cancer. The Company's commitment to the development of products for the treatment of cancer is focused on synthetic therapeutic vaccines and strategies for immunotherapeutic treatment of cancer.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.